基于UPLC-Q-TOF-MS结合网络药理学的黄褐毛忍冬保肝活性成分及其潜在靶点研究

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (9108 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To systematically identify the chemical components and explore the potential mechanisms of hepatoprotection by L. fulvotomentosa Hsu et S. C. Cheng (LFH), and provide evidences for figuring out pharmacodynamic substances. Methods: First, the main chemical components of LFH were analyzed by UPLCQTOFMS, and quickly identified by standards or references based on the MS/MS spectrometry information of all potential compounds. The absorption efficacy of drugs was predicted by Molinspiration software. Then, Swiss Target Prediction and SEA database were used to retrieve the target of the chemical components of LFH, and the acute liver injury related targets were also screened by GeneCards databases and overlapping proteins were selected as acute liver injury targets of LFH.Furthermore, the target was obtained from KOBAS 3.0 database, and the “componenttargetpathway” network model was established by Cytoscape 3.7.1 software. Results: Fifty-seven chemical constituents of LFH were screened out, among which 24 absorbed chemical components were selected by Molinspiration software and acted on 319 acute liver injury targets. Among, the chemical components, such as Cryptochlorogenic acid, Cynaroside, Chlorogenic acid, Neochlorogenic acid, Kaempferol, Quercetin, Oleanolic acid, Gardenoside, and Vogelosidemay act on the protein targets of CA2, AKR1B1, CA1, CA9, VEGFA, IL-2, ERAP1, FGF1, FGF2, ALOX, ADORA1 and CA4. The KEGG pathway analysis showed that LFH was directly or indirectly engaged in the signal pathways of PI3K-Akt, MAPK, TNF, Toll-like receptor, PPAR, Wnt, Notch and so on. Conclusion: UPLCQ-TOF-MS combined with network pharmacology may be used to preliminarily clarify the chemical composition and reveal potential mechanisms of LFH.

Received: 23 September 2020

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Chang1
	LIU Xiongwei1
	DING Jingxin1
	LI Jiaxin1
	YIN Zhigang2
	ZHOU Ying1
	3

Cite this article:

LIU Chang1,LIU Xiongwei1,DING Jingxin1等.

Chemical composition identification of hepatoprotection and potential targets by L. fulvotomentosa Hsu et S. C. Cheng based on integrated UPLC-Q-TOF-MS and network pharmacology

[J]. Journal of Jiangsu University(Medicine Edition), 2021, 31(01): 73-82.

URL:

http://zzs.ujs.edu.cn/xbyxb/EN/ OR http://zzs.ujs.edu.cn/xbyxb/EN/Y2021/V31/I01/73

［1］茅青, 贾宪生. 黄褐毛忍冬化学成分的研究\[J\]. 药学学报， 1989, 24(4):269-274.

［2］汤丹, 李会军, 钱正明, 等. 黄褐毛忍冬花蕾咖啡酰奎宁酸类成分研究\[J\].中国药学杂志, 2007, 42(20): 1537-1539.

［3］Wang X, Wei Y, Tian WY, et al.Characterization of nine compounds isolated from the acid hydrolysate of Lonicera fulvotomentosa Hsu et S. C. Cheng and evaluation of their in vitro activity towards HIV protease\[J\].Molecules,2019, 24(24):4526.

［4］杨兰，刘东波，舒利，等. 不同基源“金银花”的功能和应用研究进展\[J\].食品与机械，2020,36(1):10-19.

［5］汤瑾,刘文,苏松柏,等.金银花、山银花不同提取物对小鼠化学性肝损伤的保护作用研究\[J\].亚太传统医药,2016,12(16):9-11.

［6］Liu MH, Tong X, Wang JX, et al. Rapid separation and identification of multiple constituents in traditionalChinese medicine formula Shenqi Fuzheng Injection by ultrafast liquid chromatography combined with quadrupoletimeof flight mass spectrometry\[J\]. J Pharm Biomed Anal, 2013, 74(4): 141-155.

［7］杨岱琳, 佟玲, 李晓稳, 等. UPLCQTOF/MSE 方法分析养血清脑颗粒的化学成分\[J\]. 药学学报, 2016,51(5): 797-805.

［8］Ma YM, Zhang XZ, Su ZZ, et al. Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro\[J\]. J Ethnopharmacol, 2015，173:91-99.

［9］Bai G, Hou YY, Jiang M, et al. Integrated systems biology and chemical biology approach to exploring mechanisms of traditional Chinese medicines\[J\]. Chin Herb Med, 2016, 8(2): 99-106.

［10］Gimenez BG,Santos MS,Ferrarini M,et al.Evaluation of blockbuster drugs under the ruleoffive\[J\].Pharmazie,2010,65(2):148-152.

［11］Lipinski CA. Rule of five in 2015 and beyond:target and ligand structural limitations,ligand chemistry structure and drug discovery project decisions\[J\]. Adv Drug Deliver Rev,2016,101:34-41.

［12］张伟贤,兰天,董嘉乐,等.山柰酚抵抗对乙酰氨基酚引起的肝细胞损伤研究\[J\].世界中医药, 2019,14(1):39-43.

［13］Lee SH, Kim B, Oh MJ, et al. Persicaria hydropiper (L.) spach and its flavonoid components, isoquercitrin and isorhamnetin, activatethe Wnt/βcatenin pathway and inhibit adipocyte differentiation of 3T3L1 cells\[J\]. Phytother Res, 2011,25:1629-1635.

［14］Zhou JX, Yoshitomi H, Liu TH, et al. Isoquercitrin activates the AMPactivated protein kinase (AMPK) signal pathway in rat H4IIE cells\[J\]. BMC Complement Altern Med, 2014, 14:42.

［15］王秀芳，晏春根.木犀草苷对小鼠非酒精性脂肪肝病的作用研究\[J\].中华全科医学, 2019,17 (1):21-24,51.

［16］延华, 张颖, 王欢,等. 绿原酸抑制JNK 信号通路对非酒精性脂肪性肝病的防治作用\[J\].临床肝胆病杂志,2018,34 (2):359-363.

［17］Kuo WH,Yang SF,Hsieh YS, et al. Differential expression of carbonic anhydrase isoenzymes in various types of anemia\[J\].Clin Chim Acta, 2005, 351(1-2): 79-86.

［18］Neumeier M,Weigert J,Schafflerr A, et al.Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro\[J\]. Biochem Biophys Res Commun,2006,350(3): 731-735.

［19］Wang XF, Zhang X, Wang F, et al. FGF1 protects against APAPinduced hepatotoxicity via suppression of oxidative and endoplasmic reticulum stress\[J\].Clin Res Hepatol Gastroenterol, 2019,43(6):707-714.

［20］Wu S, Zhang W, Ma S, et al.ERK1/2 and JNK signaling synergistically modulate mitogenic effect of fibroblast growth factor 2 on liver cell\[J\].Cell Biol Int, 2018, 42(11):1511-1522.

［21］金立方,倪坚,闫俊艳,等.Hedgehog信号通路对肝脏损伤修复作用的研究进展\[J\].中国细胞生物学学报, 2019, 41(8): 1615-1621.

［22］张祎婕,肖俊丽,张小燕, 等.肝纤维化过程中HIPPO信号通路调控机制的研究进展\[J\].华中科技大学学报（医学版）,2019, 48(3):350-354.

［23］Khalaf AM,Fuentes D,Morshid AI,et al. Role of wnt/βcatenin signaling in hepatocellular carcinoma,pathogenesis, and clinical significance\[J\]. J Hepatocell Carcinoma,2018,5:61-73.

［24］Liu LJ,Xie SX,Chen YT,et al. Aberrant regulation of wnt signaling in hepatocellular carcinoma\[J\]. World J Gastroenterol,2016,22(33):7486-7499.

［25］Katoh M. Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical wnt/βcatenin signaling activation\[J\].Int J Mol Med，2018, 42(2):713-725.

［26］张剑,李作标,李嘉兴,等.Wnt/βcatenin信号通路与肝脏疾病相关性的研究进展\[J\].实用医学杂志, 2019,35(14):2347-2351.